Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients

ALK- rearrangement in non-small-cell lung cancer (NSCLC)

(2018) Xue Du et al.   Thoracic Cancer

EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China

(2018) Can Pi et al.   Thoracic Cancer

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells

(2018) Ugo Testa et al.   Cancers

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma

(2016) Shiyong Li et al.   Journal of Thoracic Oncology

Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

(2016) Pascale Tomasini et al.   Therapeutic Advances in Medical Oncology

Nivolumab: A Review in Advanced Squamous Non-Small Cell Lung Cancer

(2015) Gillian M. Keating   DRUGS

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients

(2013) Youngwook Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

(2013) Neal I. Lindeman et al.   Journal of Thoracic Oncology

Personalized therapy on the horizon for squamous cell carcinoma of the lung

(2013) Han Sang Kim et al.   LUNG CANCER

Correlation of EGFR mutation and predominant histologic subtype according to the new lung adenocarcinoma classification in Chinese patients

(2013) Zhengbo Song et al.   MEDICAL ONCOLOGY

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

(2013) Natasha Rekhtman et al.   MODERN PATHOLOGY

Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients

(2012) Akihiko Yoshizawa et al.   Journal of Thoracic Oncology

Comprehensive genomic characterization of squamous cell lung cancers

(2012)   NATURE

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

(2010) William D. Travis et al.   Journal of Thoracic Oncology